Erste Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Erste Asset Management’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$461K	Hold	15,010	–	–	﹤0.01%	522
2026 Q1	$290K	Hold	15,010	–	–	﹤0.01%	554
2025 Q4	$296K	Hold	15,010	–	–	﹤0.01%	539
2025 Q3	$456K	Sell	15,010 -2,411	-14%	-$72.3K	﹤0.01%	493
2025 Q2	$636K	Buy	17,421 +2,411	+16%	+$86.9K	0.01%	588
2025 Q1	$568K	Hold	15,010	–	–	0.01%	420
2024 Q4	$652K	Hold	15,010	–	–	0.01%	419
2024 Q3	$817K	Hold	15,010	–	–	0.01%	397
2024 Q2	$622K	Hold	15,010	–	–	0.01%	405
2024 Q1	$703K	Hold	15,010	–	–	0.01%	398
2023 Q4	$725K	Hold	15,010	–	–	0.01%	397
2023 Q3	$528K	Hold	15,010	–	–	0.01%	402
2023 Q2	$700K	Hold	15,010	–	–	0.01%	388
2023 Q1	$580K	Hold	15,010	–	–	0.01%	415
2022 Q4	$678K	Hold	15,010	–	–	0.01%	402
2022 Q3	$609K	Hold	15,010	–	–	0.01%	399
2022 Q2	$904K	Hold	15,010	–	–	0.02%	367
2022 Q1	$1.07M	Sell	15,010 -2,200	-13%	-$153K	0.02%	347
2021 Q4	$1.42M	Hold	17,210	–	–	0.03%	325
2021 Q3	$1.48M	Hold	17,210	–	–	0.03%	303
2021 Q2	$1.66M	Hold	17,210	–	–	0.03%	305
2021 Q1	$1.93M	Hold	17,210	–	–	0.05%	272
2020 Q4	$2.54M	Sell	17,210 -1,200	-7%	-$142K	0.07%	241
2020 Q3	$1.57M	Sell	18,410 -76,900	-81%	-$6.37M	0.05%	271
2020 Q2	$7.25M	Hold	95,310	–	–	0.29%	108
2020 Q1	$4.23M	Hold	95,310	–	–	0.25%	115
2019 Q4	$4.1M	Hold	95,310	–	–	0.18%	129
2019 Q3	$4.06M	Hold	95,310	–	–	0.22%	117
2019 Q2	$5.99M	Hold	95,310	–	–	0.32%	84
2019 Q1	$6.56M	Buy	95,310 +7,600	+9%	+$434K	0.37%	67
2018 Q4	$3.68M	Buy	+87,710	New	+$4.79M	0.25%	107

Other funds holding RARE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Erste Asset Management's RARE Position: Q2 2026 in Review

Erste Asset Management held its Ultragenyx Pharmaceutical (RARE) position steady in Q2 2026 at 15,010 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Erste Asset Management first reported a position in RARE in Q4 2018 and has held it in 31 quarters since. The position peaked at $7.25M in Q2 2020. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

Erste Asset Management held 15,010 shares of Ultragenyx Pharmaceutical worth $461K as of Q2 2026.
Erste Asset Management left its Ultragenyx Pharmaceutical share count unchanged in Q2 2026.
Ultragenyx Pharmaceutical made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #522 holding.
Erste Asset Management first reported a position in Ultragenyx Pharmaceutical in Q4 2018 and has held it in 31 quarters since.
Erste Asset Management's Ultragenyx Pharmaceutical position peaked at $7.25M in Q2 2020.
310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.